Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema
Condition(s):Retinitis Pigmentosa; Cystoid Macular EdemaLast Updated:September 6, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Retinitis Pigmentosa; Cystoid Macular EdemaLast Updated:September 6, 2017Completed
Condition(s):Macular Degeneration; Retinal DrusenLast Updated:October 28, 2021Completed
Condition(s):Diabetic RetinopathyLast Updated:January 18, 2020Unknown status
Condition(s):Central Serous ChorioretinopathyLast Updated:March 27, 2018Terminated
Condition(s):Fabry DiseaseLast Updated:May 2, 2017Completed
Condition(s):Myopia; Choroidal NeovascularizationLast Updated:March 19, 2014Completed
Condition(s):Diabetic Macular EdemaLast Updated:September 23, 2013Completed
Condition(s):Age Related Macular DegenerationLast Updated:August 11, 2015Unknown status
Condition(s):Diabetic RetinopathyLast Updated:May 3, 2013Terminated
Condition(s):Non-Proliferative Diabetic Retinopathy; CataractLast Updated:August 3, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.